Clinical Trials Directory

Trials / Completed

CompletedNCT04855188

Effectiveness and Safety of YVOIRE Y-Solution 540

A Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Design Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 540 Versus YVOIRE Volume Plus in Nasolabial Folds Injection

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
394 (actual)
Sponsor
LG Chem · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

To Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 540 versus YVOIRE volume plus in Nasolabial Folds Injection

Conditions

Interventions

TypeNameDescription
DEVICEYVOIRE Y-Solution 540Injection into the deep dermis layer and/or subcutaneous layer in the nasolabial folds based on the randomization assignment.
DEVICEYVOIRE volume plusInjection into the deep dermis layer and/or subcutaneous layer in the nasolabial folds based on the randomization assignment.

Timeline

Start date
2021-07-01
Primary completion
2022-09-29
Completion
2024-07-14
First posted
2021-04-22
Last updated
2024-12-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04855188. Inclusion in this directory is not an endorsement.